Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors
Authors:
- 12 June 2024
- Vol. 187 (15) , 3888-3903.e18
Abstract
No abstract availableKeywords
Funding Information
- NIDDK (DK043351, DK34854)
- National Institutes of Health (AI170632)
- National Security Agency
- NIAID (AI167993, AI116550, AI007245-35)
- eNeura Therapeutics
This publication has 65 references indexed in Scilit:
- A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseasesCell, 2023
- Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathwayCell, 2021
- Inflammasomes within Hyperactive Murine Dendritic Cells Stimulate Long-Lived T Cell-Mediated Anti-tumor ImmunityCell Reports, 2020
- Toll-like Receptors and the Control of ImmunityCell, 2020
- Aging leads to dysfunctional innate immune responses to TLR2 and TLR4 agonistsAging Clinical and Experimental Research, 2018
- Aging of the immune system: Focus on inflammation and vaccinationEuropean Journal of Immunology, 2016
- Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in AgingCell Metabolism, 2013
- Impact of aging on dendritic cell functions in humansAgeing Research Reviews, 2011
- Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunityEuropean Journal of Immunology, 2009
- Mechanisms of murine dendritic cell antitumor dysfunction in agingCancer Immunology, Immunotherapy, 2008